Male breast cancer has also been shown to have a higher frequency of hormone receptor (HR), estrogen receptor (ER) and progesterone receptor (PR), expression (80–90%) compared to females (75%) [4], [5]. This evidence concerns the gene NR4A1 and male breast carcinoma.